or Try an Advanced Search...

    Technical Analysis for IGC - India Globalization Capital Inc.

    Grade Last Price % Change Price Change
    F 0.33 -2.86% -0.01
    IGC closed down 2.86 percent on Wednesday, November 20, 2024, on 46 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical IGC trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Below Lower BB Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction -2.86%
    Lower Bollinger Band Walk Weakness -2.86%
    Inside Day Range Contraction -2.86%
    Below Lower BB Weakness -2.86%
    Lower Bollinger Band Touch Weakness -2.86%
    Oversold Stochastic Weakness -2.86%
    Older End-of-Day Signals for IGC ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Lower Bollinger Band about 20 hours ago
    Fell Below Previous Day's Low about 20 hours ago
    Down 2 % about 20 hours ago
    Down 1% about 20 hours ago
    Up 1% about 20 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    IGC Chart by TradingView
    Basic chart:

    Profile

    India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Clinical Medicine Pain Alzheimer's Disease Cannabis Parkinson's Disease Disorders Dog Medicinal Plants Psychiatric Diagnosis Epilepsy Herbalism Cannabis Smoking Medical Cannabis Nausea

    Is IGC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 IGC Pharma GAAP EPS of -$0.02 beats by $0.01, revenue of $0.41M beats by $0.21M
    Nov 14 IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline
    Nov 6 IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer’s and Weight Loss Therapies
    Oct 17 IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1
    Oct 3 IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge
    Sep 18 IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment
    Sep 4 IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease
    Aug 26 IGC Announces Results of its 2024 Annual Stockholders Meeting
    Aug 22 IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease
    Aug 20 IGC Pharma Expands Drug Portfolio to Metabolic Disorders with IGC-1A, A Potential New GLP-1 Agonist
    See more IGC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.9099
    52 Week Low 0.2501
    Average Volume 419,311
    200-Day Moving Average 0.41
    50-Day Moving Average 0.37
    20-Day Moving Average 0.38
    10-Day Moving Average 0.36
    Average True Range 0.02
    RSI (14) 33.77
    ADX 30.68
    +DI 11.34
    -DI 19.20
    Chandelier Exit (Long, 3 ATRs) 0.36
    Chandelier Exit (Short, 3 ATRs) 0.40
    Upper Bollinger Bands 0.42
    Lower Bollinger Band 0.34
    Percent B (%b) -0.03
    BandWidth 21.45
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0058
    Fundamentals Value
    Market Cap 21.24 Million
    Num Shares 63.7 Million
    EPS -0.20
    Price-to-Earnings (P/E) Ratio -1.67
    Price-to-Sales 14.24
    Price-to-Book 1.38
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.36
    Resistance 3 (R3) 0.36 0.36 0.36
    Resistance 2 (R2) 0.36 0.35 0.36 0.36
    Resistance 1 (R1) 0.35 0.34 0.34 0.34 0.35
    Pivot Point 0.34 0.34 0.34 0.34 0.34
    Support 1 (S1) 0.33 0.33 0.32 0.32 0.31
    Support 2 (S2) 0.32 0.33 0.32 0.31
    Support 3 (S3) 0.31 0.32 0.31
    Support 4 (S4) 0.30